Systemic chemotherapy in patients with indwelling ureteral stenting

International Journal of Urology

Volumn 12, Issue 6, 2005, Pages 548-551

  Oh, Seung June ^a   Ku, Ja Hyeon ^a,b   Byun, Seok Soo ^a   Lee, Sang Wook ^a   Jeon, Hwang Gyun ^a   Kim, Hyeon Hoe ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Acute pyelonephritis; Chemotherapy; Stent; Ureteral obstruction

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE PYELONEPHRITIS; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANUS CANCER; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENDOMETRIUM CANCER; FEMALE; FEVER; FOLLOW UP; HUMAN; INCIDENCE; INDWELLING CATHETER; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OVARY CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH CANCER; TREATMENT OUTCOME; URETER OBSTRUCTION; URETER STENT; UTERINE CERVIX CANCER;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; EQUIPMENT DESIGN; FEMALE; FEVER; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PYELONEPHRITIS; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; TIME FACTORS; URETERAL OBSTRUCTION; URINARY DIVERSION;

EID: 23244432332     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2005.01089.x     Document Type: Article

References (11)

1. Ekici S, Sahin A, Ozen H. Percutaneous nephrostomy in the management of malignant ureteral obstruction secondary to bladder cancer. J. Endourol. 2001; 15: 827-9.
2. Park DS, Park JH, Lee YT. Percutaneous nephrostomy versus indwelling ureteral stents in patients with bilateral nongenitourinary malignant extrinsic obstruction. J. Endourol. 2002; 16: 153-4.
3. Chiou RK, Chang WY, Horan JJ. Ureteral obstruction associated with prostate cancer: the outcome after percutaneous nephrostomy. J. Urol. 1990; 143: 957-9.
4. Andriole GL, Bettmann MA, Garnick MB, Richie JP. Indwelling double-J ureteral stents for temporary and permanent urinary drainage: experience with 87 patients. J. Urol. 1984; 131: 239-41.
5. Barton DP, Morse SS, Fiorica JV, Hoffman MS, Roberts WS, Cavanagh D. Percutaneous nephrostomy and ureteral stenting in gynecologic malignancies. Obstet. Gynecol. 1992; 80: 805-811.
6. Hyppolite JC, Daniels ID, Friedman EA. Obstructive uropathy in gynecologic malignancy. Detrimental effect of intraureteral stent placement and value of percutaneous nephrostomy. ASAIO J. 1995; 41: M318-24.
7. Lau MW, Temperley DE, Mehta S, Johnson RJ, Barnard RJ, Clarke NW. Urinary tract obstruction and nephrostomy drainage in pelvic malignant disease. Br. J. Urol. 1995; 76: 565-9.
8. Docimo SG, Dewolf WC. High failure rate of indwelling ureteral stents in patients with extrinsic obstruction: experience at 2 institutions. J. Urol. 1989; 142: 277-9.
9. Yossepowitch O, Lifshitz DA, Dekel Y et al. Predicting the success of retrograde stenting for managing ureteral obstruction. J. Urol. 2001; 166: 1746-9.
10. Jenkins CN, Marcus AJ. The value of antegrade stenting for lower ureteric obstruction. J. R. Soc. Med. 1995; 88: 446-9.
11. Dudley BS, Gershenson DM, Kavanagh JJ et al. Percutaneous nephrostomy catheter use in gynecologic malignancy: M.D. Anderson Hospital experience. Gynecol. Oncol. 1986; 24: 273-8.